Authors: Lawton JM, Conway LT, Crosson JT, Smith CL, Abraham PA
PMID: 3994472
Abstract
A single 45-g dose of intravenous ascorbic acid, a metabolic precursor of oxalate, was administered to a patient as adjuvant therapy for primary amyloidosis and the nephrotic syndrome. Acute oliguric renal failure occurred. Postmortem histopathologic examination of renal tissue revealed extensive intratubular deposition of crystalline material, which was confirmed as calcium oxalate by a microincineration technique. There were no extrarenal deposits of calcium oxalate. Plasma oxalate and ascorbic acid concentrations were increased. We conclude that therapy with high-dose ascorbic acid is a potential cause of oxalate nephropathy.
Keywords: Acute oxalate nephropathy, ascorbic acid
Source: https://pubmed.ncbi.nlm.nih.gov/3994472/
Archive: https://archive.is/HDwIU
